![Douglas Calder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Calder
Director/Board Member at
ZEVRA THERAPEUTICS, INC.
Net worth: 4 657 $ as of 30/05/2026
Profile
Douglas W.
Calder is currently an Independent Director at Zevra Therapeutics, Inc. since 2023, a Director at BioFlorida, Inc. since 2019, a Director at Nextgennk since 2019, an Independent Director at Lunai Bioworks, Inc. since 2024, and a Member of the Society For Natural Immunity since 2018.
Former roles include Director-Investor Relations & Public Relations at Accentia Biopharmaceuticals, Inc. from 2012 to 2013, President & Director at Vycellix, Inc., VP-Strategic Planning & Capital Markets at BioVest International, Inc. from 2012 to 2013, Executive Vice President at Pulse Evolution Corp., President at VyGen-Bio, Inc., and Portfolio Manager at Dean Witter Reynolds, Inc. and Gruntal & Co. LLC.
Education includes undergraduate studies at Florida State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LUNAI BIOWORKS, INC. 0.03% | 09/04/2026 | 1,512 ( 0.03% ) | 4 657 $ | 30/05/2026 |
| 05/04/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
Douglas Calder active positions
| Companies | Position | Start |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Director/Board Member | 24/04/2023 |
| LUNAI BIOWORKS INC. | Director/Board Member | 13/10/2024 |
Nextgennk | Director/Board Member | 31/05/2019 |
BioFlorida, Inc.
 BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services Provides infrastructure to exchange information and ideas through industry specific programming, education, networking and legislative initiatives. | Director/Board Member | 31/12/2018 |
Former positions of Douglas Calder
| Companies | Position | End |
|---|---|---|
BioVest International, Inc.
 BioVest International, Inc. Medical SpecialtiesHealth Technology Develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers | Investor Relations Contact | 15/07/2013 |
| ACCENTIA BIOPHARMACEUTICALS INC | Investor Relations Contact | 03/03/2013 |
Dean Witter Reynolds, Inc.
 Dean Witter Reynolds, Inc. Investment ManagersFinance Investment management | Corporate Officer/Principal | - |
Gruntal & Co. LLC
 Gruntal & Co. LLC General GovernmentGovernment Provides financial services | Corporate Officer/Principal | - |
VyGen-Bio, Inc.
 VyGen-Bio, Inc. BiotechnologyHealth Technology Develops cell & gene therapies and treatments for cancer | President | - |
Training of Douglas Calder
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
42
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology Develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers | Health Technology |
Accentia Biopharmaceuticals, Inc.
 Accentia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceuticals | Health Technology |
Zevra Therapeutics, Inc.
 Zevra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets proprietary prodrugs | Health Technology |
Lunai Bioworks, Inc.
 Lunai Bioworks, Inc. BiotechnologyHealth Technology Operates as preclinical stage biotechnology company developing technologies and therapies for HIV, HBV and cancer | Health Technology |
Pulse Evolution Corp.
 Pulse Evolution Corp. Information Technology ServicesTechnology Services Produces photorealistic digital humans and provides digital production | Technology Services |
Dean Witter Reynolds, Inc.
Dean Witter Reynolds, Inc. Investment ManagersFinance Investment management | Finance |
Gruntal & Co. LLC
Gruntal & Co. LLC General GovernmentGovernment Provides financial services | Government |
Florida State University
 Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioFlorida, Inc.
BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services Provides infrastructure to exchange information and ideas through industry specific programming, education, networking and legislative initiatives. | Commercial Services |
Vycellix, Inc.
 Vycellix, Inc. BiotechnologyHealth Technology Engages in the development of transformational platform technologies for cell & gene-based therapies | Health Technology |
Nextgennk | |
VyGen-Bio, Inc.
VyGen-Bio, Inc. BiotechnologyHealth Technology Develops cell & gene therapies and treatments for cancer | Health Technology |
- Stock Market
- Insiders
- Douglas Calder
